
Contagion, December 2021 (Vol. 06, No. 6)


Risk of inaccuracy with pulse oximeters and clinician knowledge gaps in people of color may affect sepsis evaluations and impact treatment plans.

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.

Epidemiologic and clinical lessons for the uninitiated.

Will this winter bring the feared twindemic of SARS-CoV-2 and influenza, or will another common infection reemerge?

A review of the data and circumstances that led to authorization in children ages 5 to 11 years.



A reflection on the wins and setbacks in the second year of our pandemic, 2021.

Recent study results show promising new modalities.
Advertisement
Advertisement
Trending on Contagion Live
1
Reductions in Funding, Personnel Will Leave US Less Prepared for Future Infectious Disease Outbreaks
2
Invivyd doses first participants in phase 3 COVID-19 trial of VYD2311
3
ASM Initiative Aims to Advance Phage Therapy for Drug-Resistant Infections
4
Challenges to Adopting New Therapeutics: Familiarity, Diagnostics, and Real-World Use in Persistent Bacteremia
5
